Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

NICE rejects Tyverb despite price offer

March 5, 2009 Research and Development NICE, Tyverb

NICE has rejected GSK's breast cancer drug Tyverb, despite an offer from the company to cut the cost of treatment. …
News

Obama makes ‘downpayment’ on US healthcare reform

March 5, 2009 Research and Development US, healthcare

President Barack Obama has reiterated his aim of bringing universal healthcare to the US and has put a $76.8 billion …
News

Symbicort gains COPD indication

March 4, 2009 Research and Development Symbicort

AstraZeneca's respiratory drug Symbicort can be used to help US patients with chronic obstructive pulmonary disease (COPD). The FDA has …
News

First-in-class cancer treatment Vidaza launched

March 3, 2009 Research and Development Vidaza

Vidaza, an innovative new treatment for a number of hard-to-treat blood cancers, has been launched in the UK by Celgene. …
News

Safety concerns give Raptiva ‘no way back’

March 2, 2009 Research and Development Raptiva, drug safety

News

Chinese move marks ‘globalisation’ of Bayer Schering R&D

March 2, 2009 Research and Development Asia, Bayer, China

Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …
News

Novartis vaccine recalled after contamination scare

February 26, 2009 Manufacturing and Production, Research and Development Vaccine

Novartis has recalled UK supplies of its meningitis C vaccine after tests found some batches contaminated with bacteria. The recall …
News

Time running out for pharma sales and marketing

February 26, 2009 Research and Development, Sales and Marketing pwC, strategy

The pharma industry's current sales and marketing model will be defunct in the next ten years. That is the stark …
News

Europe approves Lilly’s Plavix rival

February 25, 2009 Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …
News

Future of new AZ asthma drug uncertain after phase III failure

February 25, 2009 Research and Development AZ, respiratory

News

NovaBiotics: a rising star for 2009

February 24, 2009 Research and Development NovaBiotics

Biologics company NovaBiotics has been dubbed a Rising Star for 2009 by the Scottish arm of the BioIndustry Association. The …
News

R&D tax credits among anticipated changes for US healthcare

February 24, 2009 Research and Development US, healthcare

With the election of Barack Obama, widespread changes are anticipated for US healthcare and ultimately for the pharmaceutical industry. Although …
News

Bringing global trials teams together

February 23, 2009 Research and Development clinical trials, global

The world is getting bigger and smaller at the same time. When the internet began to really catch on about …
Feature

Raptiva suspended in Europe over safety concerns

February 20, 2009 Research and Development, Sales and Marketing Europe, Rapitva

Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …
News

Servier claims victory over NICE in osteoporosis

February 19, 2009 Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026